These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 36502514

  • 21. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y, Aya Y, Megumi U, Shunichi K, Masafumi S, Hiroaki M, Masahiko K, Shinsuke K, Manabu U, Kenichiro H, Fumiaki A, Nozomi A, Toshitaka M, Masayoshi Y, Chikako K, Yoshinao M, Tatsuo S, Masahiko K.
    Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
    [Abstract] [Full Text] [Related]

  • 22. [Interstitial pneumonia complicating amyopathic dermatomyositis: a case report].
    Jamoussi SK, Dhaou BB, Boussema F, Kochbati S, Baili L, Aouina H, Cherif O, Bouacha H, Rokbani L.
    Rev Pneumol Clin; 2009 Dec; 65(6):353-6. PubMed ID: 19995656
    [Abstract] [Full Text] [Related]

  • 23. Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis.
    Teruya A, Kawamura K, Ichikado K, Sato S, Yasuda Y, Yoshioka M.
    Chest; 2013 Dec; 144(6):1934-1936. PubMed ID: 24297126
    [Abstract] [Full Text] [Related]

  • 24. Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies.
    Sato S, Kuwana M, Fujita T, Suzuki Y.
    Mod Rheumatol; 2012 Aug; 22(4):625-9. PubMed ID: 22124544
    [Abstract] [Full Text] [Related]

  • 25. Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis.
    Takada T, Aoki A, Asakawa K, Sakagami T, Moriyama H, Narita I, Sato S.
    Respir Med; 2015 Sep; 109(9):1174-80. PubMed ID: 26187000
    [Abstract] [Full Text] [Related]

  • 26. Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report.
    Ishikawa Y, Kasuya T, Fujiwara M, Kita Y.
    Medicine (Baltimore); 2020 Sep 11; 99(37):e21943. PubMed ID: 32925726
    [Abstract] [Full Text] [Related]

  • 27. Successful delivery in a patient with clinically amyopathic dermatomyositis during pregnancy despite first-trimester acute exacerbation of interstitial lung disease.
    Ochiai M, Sato E, Tanaka E, Tochihara M, Shimizu Y, Osawa H, Sidara K, Sugimoto N, Hoshi D, Kawaguchi Y, Taniguchi A, Yamanaka H.
    Mod Rheumatol; 2017 Mar 11; 27(2):364-368. PubMed ID: 25619281
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S, Arita M, Morita M, Ikeo S, Ito A, Tokioka F, Noyama M, Misaki K, Notohara K, Ishida T.
    BMC Pulm Med; 2015 Dec 09; 15():159. PubMed ID: 26651481
    [Abstract] [Full Text] [Related]

  • 30. Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients.
    Sun Y, Liu Y, Yan B, Shi G.
    Rheumatol Int; 2013 May 09; 33(5):1295-302. PubMed ID: 23143553
    [Abstract] [Full Text] [Related]

  • 31. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ, Park JK, Kang EH, Kwon HM, Lee YJ, Song YW, Lee EB.
    Rheumatol Int; 2016 Jan 09; 36(1):125-31. PubMed ID: 26223808
    [Abstract] [Full Text] [Related]

  • 32. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug 09; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ, Li YH, Zhang LH, Ma L, He WW, Jin YB, An Y, Li ZG, Ye H.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec 18; 52(6):1001-1008. PubMed ID: 33331305
    [Abstract] [Full Text] [Related]

  • 34. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
    Nishi K, Ogura M, Tamai N, Gima M, Ide K, Koinuma G, Kamei K, Ito S.
    Pediatr Rheumatol Online J; 2022 Aug 04; 20(1):60. PubMed ID: 35927666
    [Abstract] [Full Text] [Related]

  • 35. Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
    Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.
    Medicine (Baltimore); 2018 Jun 04; 97(26):e11024. PubMed ID: 29952940
    [Abstract] [Full Text] [Related]

  • 36. Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis.
    Xu Y, Yang CS, Li YJ, Liu XD, Wang JN, Zhao Q, Xiao WG, Yang PT.
    Clin Rheumatol; 2016 Jan 04; 35(1):113-6. PubMed ID: 26660480
    [Abstract] [Full Text] [Related]

  • 37. Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.
    Horai Y, Isomoto E, Koga T, Okada A, Kawashiri SY, Tamai M, Yamasaki S, Nakamura H, Origuchi T, Hamaguchi Y, Fujimoto M, Kuwana M, Kawakami A.
    Mod Rheumatol; 2013 Jan 04; 23(1):190-4. PubMed ID: 22460910
    [Abstract] [Full Text] [Related]

  • 38. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study.
    Zhou S, Lai J, Wu C, Liu Y, Liu Y, Zhao J, Xu D, Tian X, Li M, Zhao Y, Wang Y, Wang Q, Zeng X.
    Front Immunol; 2022 Jan 04; 13():928861. PubMed ID: 35983058
    [Abstract] [Full Text] [Related]

  • 39. Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series.
    Saito T, Mizobuchi M, Miwa Y, Sugiyama M, Mima Y, Iida A, Kanazawa N, Morikawa T, Hayashi J, Fukuda K, Shikida Y, Suzuki T, Honda H.
    J Clin Apher; 2021 Feb 04; 36(1):196-205. PubMed ID: 32823371
    [Abstract] [Full Text] [Related]

  • 40. Management of Myositis-Associated Interstitial Lung Disease.
    Fujisawa T.
    Medicina (Kaunas); 2021 Apr 03; 57(4):. PubMed ID: 33916864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.